Familial hypercholesterolaemia

Supporting primary care to better detect familial hypercholesterolaemia (FH)


We are working to improve the identification of patients with, or at risk of, familial hypercholesterolaemia, a genetic disease which results in high blood cholesterol and an increased risk of early cardiovascular disease (CVD).

Together with our partners across our local health and care system, we are working to increase the numbers of people who have their cholesterol measured and to identify those with conditions that increase familial risk of hypercholesterolaemia.

Expanding access to genetic testing for FH via screening of electronic records and piloting a process of child-parent screening will enable early diagnosis and treatment for those at genetic risk of sudden cardiac death. This is imperative as substantial improvements in FH diagnosis have not been made despite publication of NICE (National Institute for Health & Care Excellence) clinical guidelines (CG71) and Quality Standards (QS41).


Are you a healthcare professional working to improve familial hypercholesterolaemia detection? Our team is here to support you.

For more information, or if you have any questions, please contact our Cardiovascular Disease Programme Clinical Lead, Rhiannon Edwards (rhiannon.edwards@swahsn.com).


Keep up-to-date with our latest work to improve FH detection and lipid management by signing up to the South West AHSN newsletter.